Powell Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-22,219
Closed -$643K 164
2024
Q3
$643K Buy
22,219
+8,688
+64% +$253K 0.3% 50
2024
Q2
$379K Hold
13,531
0.2% 72
2024
Q1
$375K Hold
13,531
0.2% 72
2023
Q4
$390K Hold
13,531
0.22% 72
2023
Q3
$449K Sell
13,531
-477
-3% -$16.9K 0.27% 62
2023
Q2
$514K Sell
14,008
-241
-2% -$9.38K 0.3% 58
2023
Q1
$581K Buy
14,249
+2
+0% +$86 0.32% 55
2022
Q4
$730K Sell
14,247
-32
-0.2% -$1.53K 0.42% 39
2022
Q3
$625K Buy
14,279
+2,853
+25% +$139K 0.41% 40
2022
Q2
$599K Buy
11,426
+2
+0% +$102 0.36% 40
2022
Q1
$591K Buy
11,424
+35
+0.3% +$1.82K 0.34% 45
2021
Q4
$673K Buy
11,389
+2
+0% +$99 0.38% 40
2021
Q3
$490K Buy
11,387
+2
+0% +$89 0.3% 49
2021
Q2
$446K Sell
11,385
-1,216
-10% -$47.3K 0.27% 47
2021
Q1
$457K Buy
12,601
+3
+0% +$107 0.3% 45
2020
Q4
$464K Sell
12,598
-1,205
-9% -$44.2K 0.35% 44
2020
Q3
$481K Sell
13,803
-570
-4% -$20K 0.41% 37
2020
Q2
$446K Buy
14,373
+8
+0.1% +$272 0.43% 41
2020
Q1
$445K Sell
14,365
-707
-5% -$24.1K 0.54% 38
2019
Q4
$560K Buy
+15,072
New +$537K 0.58% 37

Other funds holding PFE

Powell Investment Advisors's PFE Position: Q4 2024 in Review

Powell Investment Advisors sold out of Pfizer (PFE) in Q4 2024, closing a stake of 22,219 shares — an estimated $643K sold.

Powell Investment Advisors first reported a position in PFE in Q4 2019 and held it in 20 quarters. The position peaked at $730K in Q4 2022. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Powell Investment Advisors reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Powell Investment Advisors sold 22,219 Pfizer shares in Q4 2024, an estimated $643K.
  • Powell Investment Advisors first reported a position in Pfizer in Q4 2019 and held it in 20 quarters.
  • Powell Investment Advisors's Pfizer position peaked at $730K in Q4 2022.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Powell Investment Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.